Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000477

Drug Information
SynonymsCAS-59-97-2; Spectrum_000731; 2-Benzyl-2-imidazoline; DivK1c_000328; Priscol; 2-(phenylmethyl)-4,5-dihydro-1H-imidazole; L000960; NCGC00016271-02; Artonil; Priscoline; SPBio_000988; DB00797; Vasimid; CID5504; 2-IMIDAZOLINE, 2-BENZYL-; KBio1_000328; Tolazolin; Olitensol; Tolazolinum [INN-Latin]; Benzylimidazoline; KBio2_006347; KBioGR_000793; 59-97-2 (mono-hydrochloride); NCGC00016271-01; BSPBio_002068; Spectrum4_000357; 293490_ALDRICH; NSC35110; Benzolin; Imidaline; Tolazoline [INN:BAN]; KBio3_001568; MolPort-002-626-489; Tolazine [veterinary] (TN); Divascol; NSC 35110; D08614; Tolazine [veterinary]; Ciba 3259; 2-BENZYL-4,5-IMIDAZOLINE HCl; tolazoline; 2-Benzyl-4,5-imidazoline; Spectrum5_001788; NINDS_000328; WLN: T5M CN BUTJ B1R; Phenylmethylimidazoline; BRN 0128757; Kasimid; KBio2_003779; 59-97-2; IDI1_000328; 59-98-3; Prestwick1_000060; Spectrum3_000594; Imidalin; Spectrum2_001204; Benzolin (VAN); AKOS000357643; 1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)-; Peripherine; Tolazoline Monohydrochloride; UNII-CHH9H12AQ3; Prestwick2_000060; 4,5-Dihydro-2-(phenylmethyl)-1H-imidazole; Pridazole; Tolazolina; C07147; Tolazolinum; NCGC00016271-03; SPBio_002140; 1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)-; 2-Benzyl-2-imidazoline; Prestwick0_000060; Benzidazol; Tolazolina [INN-Spanish]; 2-Benzyl-4,5-dihydro-1H-imidazole; Benzolin (vasodilator) (VAN); STOCK4S-93327; 5-23-06-00488 (Beilstein Handbook Reference); KBio2_001211; BPBio1_000241; Benzalolin; AC1L1KHM; KBioSS_001211; Vasodil; Benzolin (vasodilator); EINECS 200-448-9; 1H-Imidazole, 4,5-dihydro-2-(phenylmethyl)- (9CI); BSPBio_000219; C10H12N2; Tolazoline (INN); BRD-K46211610-003-05-1; Benzazoline; Lambril; Dilatol ASI; CHEBI:28502; LS-79571; Prestwick3_000060; Vasodilatan; 2-Benzylimidazoline; CHEMBL770; Prefaxil    
IndicationPeripheral vasoconstrictionApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassVasodilator Agents    
CAS NumberCAS 59-98-3
PubChem Compound IDCID 5504.    
PubChem Substance IDSID 9356.    
SuperDrug ATC IDC04AB02;    
SuperDrug CAS ID000059983;    
TargetAlpha adrenergic receptorAntagonist[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 006403 To Reference
Ref 2Comparative effects of tolazoline and nitroprusside on human isolated radial artery. Ann Thorac Surg. 2006 Jan;81(1):125-31. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543